TELA Bio, Inc. (NASDAQ:TELA – Get Rating) – Equities researchers at Jefferies Financial Group cut their Q1 2022 EPS estimates for TELA Bio in a report released on Monday, March 21st. Jefferies Financial Group analyst Z. Weiner now anticipates that the company will post earnings of ($0.44) per share for the quarter, down from their […]
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) insider Ew Healthcare Partners Fund 2, acquired 2,331 shares of the company’s stock in a transaction that occurred on Wednesday, March 16th. The shares were acquired at an average price of $11.65 per share, with a total value of $27,156.15. The acquisition was disclosed in a filing with […]
/PRNewswire/ Verified Market Research recently published a report, "Biosurgery Market" By Type (Sealants, Adhesion Barriers, Soft Tissue Attachments), By.
The rising clearance of Biosurgery products by regulatory authorities and the availability of multifunctional products that accelerate healing and help reduce post-surgical recovery duration